AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Fangyuan Hu
Public Documents
2
September 25, 2024
Endocrine toxicities in Chimeric Antigen Receptor T-Cell Therapy: A pharmacovigilance...
jizhou liang, Fangyuan Hu, Yinghong Zhai, et al.
May 15, 2021
Safety of SGLT2 Inhibitors: A Pharmacovigilance Study From 2015 to 2020 Based on FDA...
Xiang Zhou, Xiaofei Ye, Yinghong Zhai, et al.